Cargando…

Aberrant MAPK Signaling Offers Therapeutic Potential for Treatment of Ovarian Carcinoma

Ovarian cancer remains the most lethal gynecological malignancy worldwide due to lack of effective screening, vague early symptoms, poor description of biomarkers, and absence of effective treatment regimes. Epithelial ovarian carcinoma (EOC) is categorized into five distinct disease subtypes which...

Descripción completa

Detalles Bibliográficos
Autores principales:	Colic, Eva, Patel, Preya U, Kent, Oliver A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9645123/ https://www.ncbi.nlm.nih.gov/pubmed/36388156 http://dx.doi.org/10.2147/OTT.S361512

Ejemplares similares

Mitochondrial Dysfunction Pathway Alterations Offer Potential Biomarkers and Therapeutic Targets for Ovarian Cancer
por: Shen, Liang, et al.
Publicado: (2022)

A comprehensive molecular analysis of 113 primary ovarian clear cell carcinomas reveals common therapeutically significant aberrations
por: Stružinská, Ivana, et al.
Publicado: (2023)

Therapeutic and prognostic implications of NOTCH and MAPK signaling in bladder cancer
por: Schulz, Gerald B., et al.
Publicado: (2021)

Mitochondria Deregulations in Cancer Offer Several Potential Targets of Therapeutic Interventions
por: Musicco, Clara, et al.
Publicado: (2023)

Aberrant Lipid Metabolism: An Emerging Diagnostic and Therapeutic Target in Ovarian Cancer
por: Pyragius, Carmen E., et al.
Publicado: (2013)

Aberrant Cholesterol Metabolism in Ovarian Cancer: Identification of Novel Therapeutic Targets
por: He, Jiangnan, et al.
Publicado: (2021)

Primary cilia and aberrant cell signaling in epithelial ovarian cancer
por: Egeberg, Dorte L, et al.
Publicado: (2012)

RNA Therapeutic Options to Manage Aberrant Signaling Pathways in Hepatocellular Carcinoma: Dream or Reality?
por: Sartorius, Kurt, et al.
Publicado: (2022)

The promising therapeutic potentials of ginsenosides mediated through p38 MAPK signaling inhibition
por: Arafa, El-Shaimaa A., et al.
Publicado: (2021)

Prognostic impact of chromosome aberrations in ovarian cancer.
por: Pejovic, T., et al.
Publicado: (1992)

The p38 MAPK Signaling Activation in Colorectal Cancer upon Therapeutic Treatments
por: Pranteda, Angelina, et al.
Publicado: (2020)

Modulating AHR function offers exciting therapeutic potential in gut immunity and inflammation
por: Chen, Yue, et al.
Publicado: (2023)

WNT/β-catenin signaling in hepatocellular carcinoma: The aberrant activation, pathogenic roles, and therapeutic opportunities
por: Gajos-Michniewicz, Anna, et al.
Publicado: (2023)

Identification of core aberrantly expressed microRNAs in serous ovarian carcinoma
por: Chen, Steven F., et al.
Publicado: (2018)

Aberrant regulation of Wnt signaling in hepatocellular carcinoma
por: Liu, Li-Juan, et al.
Publicado: (2016)

Beside P53 and PTEN: Identification of molecular alterations of the RAS/MAPK and PI3K/AKT signaling pathways in high-grade serous ovarian carcinomas to determine potential novel therapeutic targets
por: Chen, Shuhui, et al.
Publicado: (2016)

KRAS and MAPK1 Gene Amplification in Type II Ovarian Carcinomas
por: Rahman, Mohammed Tanjimur, et al.
Publicado: (2013)

Multiomics characterization implicates PTK7 in ovarian cancer EMT and cell plasticity and offers strategies for therapeutic intervention
por: Raivola, Juuli, et al.
Publicado: (2022)

MAPK/ERK Signaling Pathway in Hepatocellular Carcinoma
por: Moon, Hyuk, et al.
Publicado: (2021)

Deubiquitinases and the new therapeutic opportunities offered to cancer
por: Pfoh, Roland, et al.
Publicado: (2015)

Respiratory tissue-associated commensal bacteria offer therapeutic potential against pneumococcal colonization
por: Yildiz, Soner, et al.
Publicado: (2020)

Cancer glycomics offers potential biomarkers and therapeutic targets in the framework of 3P medicine
por: Guo, Yuna, et al.
Publicado: (2022)

Concomitant BET and MAPK blockade for effective treatment of ovarian cancer
por: Jing, Ying, et al.
Publicado: (2015)

A dynamic actin cytoskeleton is required to prevent constitutive VDAC-dependent MAPK signalling and aberrant lipid homeostasis
por: Davis, Jack, et al.
Publicado: (2023)

Inferring Aberrant Signal Transduction Pathways in Ovarian Cancer from TCGA Data
por: Neapolitan, Richard, et al.
Publicado: (2014)

Aberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic Opportunities
por: De Matteis, Serena, et al.
Publicado: (2018)

CUEDC2 Contributes to Cisplatin-Based Chemotherapy Resistance in Ovarian Serious Carcinoma by Regulating p38 MAPK Signaling
por: Wang, Aichun, et al.
Publicado: (2019)

Activation of MAPK signalling results in resistance to saracatinib (AZD0530) in ovarian cancer
por: McGivern, Niamh, et al.
Publicado: (2017)

Genomic aberrations in borderline ovarian tumors
por: Micci, Francesca, et al.
Publicado: (2010)

Aberrant Sialylation in Cancer: Biomarker and Potential Target for Therapeutic Intervention?
por: Pietrobono, Silvia, et al.
Publicado: (2021)

Aberrant Signaling Pathways in Squamous Cell Lung Carcinoma
por: Shi, Ivy, et al.
Publicado: (2011)

Aberrant WNT/β-catenin signaling in parathyroid carcinoma
por: Svedlund, Jessica, et al.
Publicado: (2010)

STAT3 signaling in ovarian cancer: a potential therapeutic target
por: Liang, Renba, et al.
Publicado: (2020)

Adjuvant radiotherapy for the primary treatment of adrenocortical carcinoma: are we offering the best?
por: Srougi, Victor, et al.
Publicado: (2017)

MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges
por: Moustardas, Petros, et al.
Publicado: (2023)

Integration analysis of MKK and MAPK family members highlights potential MAPK signaling modules in cotton
por: Zhang, Xueying, et al.
Publicado: (2016)

Over-expression of RALYL suppresses the progression of ovarian clear cell carcinoma through inhibiting MAPK and CDH1 signaling pathways
por: Xia, Ye, et al.
Publicado: (2021)

A transcriptomic analysis based on aberrant methylation levels revealed potential novel therapeutic targets for nasopharyngeal carcinoma
por: Lyu, Mo, et al.
Publicado: (2022)

Aberrant Expression of Folate Metabolism Enzymes and Its Diagnosis and Survival Prediction in Ovarian Carcinoma
por: Chen, Jia, et al.
Publicado: (2019)

Microbiome-derived antimicrobial peptides offer therapeutic solutions for the treatment of Pseudomonas aeruginosa infections
por: Mulkern, Adam J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ssjllqjlq2h7799gacsrk38ane